Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
PDF) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
Overview of microRNAs as liquid biopsy biomarkers for colorectal cancer sub-type profiling and chemoresistance
Up-regulated miR-133a orchestrates epithelial-mesenchymal transition of airway epithelial cells | Scientific Reports
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction) - Journal of Molecular and Cellular Cardiology
Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia/reperfusion injury and infarction: Involvement of redox signalling - ScienceDirect
IJMS | Free Full-Text | Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
Frontiers | Modes of action and diagnostic value of miRNAs in sepsis
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes | Scientific Reports
MicroRNAs in cardiovascular disease - ScienceDirect
Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases
Cells | Free Full-Text | MicroRNAs in Cardiac Diseases
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism | Scientific Reports
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction
MicroRNA plasma expression over time. A miR-1, B miR-133a, C miR-30a, D... | Download Scientific Diagram
Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage | Circulation: Cardiovascular Genetics
Plasma Circulating Extracellular RNAs in Left Ventricular Remodeling Post-Myocardial Infarction - eBioMedicine
Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy
ORIGINAL ARTICLE Plasma MicroRNA-133a as a Potential Predictor for Coronary Artery Stenosis Severity
